Overview Excilite μ combines the advantages of conventional UV lamp phototherapy (eg NB-UVB or PUVA) and excimer laser therapy. The device delivers monochromatic 308 nm emission with high intensity (50 mW/cm²) and a large treatment spot (30 cm²). Special filters shield healthy perilesional skin, minimizing erythema and burns. No drug administration is required and repigmentation is accelerated, making it effective across multiple anatomical areas. Compared with excimer lasers, Excilite μ treats larger areas, enables faster sessions and reduces maintenance costs.
Key features - Monochromatic emission at 308 nm (MEL@308 nm)
- High intensity: 50 mW/cm²
- Large spot size: 30 cm²
- Perilesional skin protection via special filters
- Minimizes side effects (erythema, burns)
- No adjunctive drug administration required
- Faster repigmentation and reduced treatment times
- Lower maintenance costs vs. excimer lasers
Clinical highlights - Clinically proven, long-lasting technology
- Safe wavelength profile that limits side effects
- Short treatment times suitable for targeted lesions
Applications - Vitiligo
- Psoriasis
- Alopecia
- Atopic dermatitis
Technical specifications - Source: MEL 308 nm
- Wavelength: 308 nm (monochromatic)
- Emission: Monochromatic
- Intensity: 50 mW/cm²
- Spot size: 30 cm²
- Indications: Vitiligo, Psoriasis, Alopecia, Atopic dermatitis
- Benefits: protects perilesional healthy skin, minimizes erythema and burns, no drugs required, accelerates repigmentation, faster treatments, reduced maintenance costs
- Category: DEKA Aesthetics